CME Group and Nasdaq Extend Partnership for Nasdaq-100 Futures Until 2039

CME Group and Nasdaq Extend Partnership Until 2039

In a significant move for the trading industry, CME Group and Nasdaq have announced a ten-year extension of their exclusive licensing agreement related to futures and options based on the Nasdaq-100 Index. This partnership, which has been thriving for nearly three decades, will now last through 2039, enabling traders to access one of the world's most actively traded financial products.

CME Group, recognized as the leading derivatives marketplace globally, boasts the largest equity index futures complex. According to Terry Duffy, Chairman and CEO of CME Group, this extension will ensure global market participants will continue to benefit from seamless access to highly liquid Nasdaq futures and options. Duffy emphasized the significance of these products, which have become vital tools for traders looking to manage risk and gain exposure to the 100 largest non-financial companies listed on Nasdaq.

In his remarks, Duffy stated, "Building on nearly 30 years of success, our partnership has enabled clients to manage risk or gain exposure to the 100 largest non-financial companies listed on Nasdaq, while providing significant capital efficiencies for those trading across our equity index complex."

On the other end, Adena Friedman, Chair and CEO of Nasdaq, highlighted how the Nasdaq-100 Index has evolved into a cornerstone for modern investing. It reflects the performance of companies that lead in innovation and drive economic transformation. She mentioned, "This ten-year extension reflects our shared commitment to delivering enduring value through trusted benchmark products, reinforcing the infrastructure that enables global participation in the equity markets."

The journey of Nasdaq-100 futures began in 1996, and in 1999, CME Group introduced the E-mini Nasdaq-100 futures, which have since become some of the most traded equity index futures contracts worldwide. Recent statistics showcase a remarkable growth trajectory for CME Group's Nasdaq-100 futures and options, with the average daily volume surging over 100% since the last licensing agreement in 2019. In fact, the average daily volume has reached upwards of 2.5 million contracts in the current year, marking a 22% year-over-year increase. Moreover, the Micro E-mini Nasdaq-100 futures have shown a 39% increase, demonstrating robust demand.

This extension not only strengthens the long-standing relationship between CME Group and Nasdaq but also fortifies the framework that facilitates market integrity and investor confidence in the securities industry. It is clear that the future is bright for both the CME Group and Nasdaq as they look to innovate and expand their offerings.

For additional details regarding E-mini Nasdaq futures and options, market participants can visit CME Group's official site. Through such collaborations, both companies aim to deliver enhanced trading experiences for their clients, ensuring they can navigate the complexities of the market with confidence.

Given the transformative nature of the financial landscape and the unpredictable economic environment, the ongoing partnership will likely serve as a crucial element in supporting the trading community's needs over the coming decade. As technology continues to evolve and reshape trading dynamics, CME Group and Nasdaq are strategically positioned to lead and adapt, reinforcing their commitment to serve traders and investors worldwide.